# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA697071 | F | Antiviral activity at 10-30 uM determined in a culture of Influenza A; IA = inactive | influenza | 1 | organism-based format | Scientific Literature | ||
2. | ALA697072 | F | Antiviral activity at <=320 uM determined in a culture of Influenza A; IA = inactive | influenza | 2 | organism-based format | Scientific Literature | ||
3. | ALA697073 | F | Antiviral activity at <=320 uM determined in a culture of Influenza A; IA = inactive | influenza | 2 | organism-based format | Scientific Literature | ||
4. | ALA697074 | F | Concentration required for reduction of plaque against influenza A | influenza | 7 | organism-based format | Scientific Literature | ||
5. | ALA697075 | F | Concentration required for reduction of plaque against influenza A; Not determined | influenza | 10 | organism-based format | Scientific Literature | ||
6. | ALA697076 | F | Antiviral activity at <=320 uM determined in a culture of Influenza A; IA = inactive | unidentified influenza virus | 1 | organism-based format | Scientific Literature | ||
7. | ALA697077 | F | In vitro antiviral activity against influenza A virus (chile); Compound was inactive at 100 uM and 1000 uM respectively. | Influenza A virus | 7 | organism-based format | Scientific Literature | ||
8. | ALA697078 | F | Antiviral activity against influenza A virus determined in chicken embryo cells (CEC) by plaque reduction assay method. | Influenza A virus | 17 | organism-based format | Scientific Literature | ||
9. | ALA877710 | F | Effective dose required to reduce virus induced cytopathogenicity by Influenza A(H1N1,Fu 88) was determined | Influenza A virus | 3 | organism-based format | Scientific Literature | ||
10. | ALA699361 | F | Effective dose required to reduce virus induced cytopathogenicity by Influenza A(H1N1,Fu 88) was determined; Not tested | Influenza A virus | 1 | organism-based format | Scientific Literature | ||
11. | ALA699362 | F | Effective dose required to reduce virus- induced cytopathogenicity; Not tested | Influenza A virus | 1 | organism-based format | Scientific Literature | ||
12. | ALA699363 | F | In vitro antiviral activity was evaluated in a plaque reduction assay against influenza A | Influenza A virus | 8 | organism-based format | Scientific Literature | ||
13. | ALA699364 | F | Inhibitory concentration of compound against formation of Influenza A virus (WSN) plaque in plaque reduction assay | Influenza A virus | 2 | organism-based format | Scientific Literature | ||
14. | ALA699365 | F | Inhibition of plaque formation | Influenza A virus | 10 | organism-based format | Scientific Literature | ||
15. | ALA699366 | F | In vitro antiviral activity against Influenza A. | Influenza A virus | 18 | organism-based format | Scientific Literature | ||
16. | ALA699367 | F | Inhibitory concentration by Plaque reduction assay | Influenza A virus | 10 | organism-based format | Scientific Literature | ||
17. | ALA699368 | F | Inhibition of plaque formation not determined | Influenza A virus | 1 | organism-based format | Scientific Literature | ||
18. | ALA699369 | F | Inhibition of plaque formation | Influenza A virus | 1 | organism-based format | Scientific Literature | ||
19. | ALA699370 | F | Inhibitory concentration by Plaque reduction assay; range- 13-27ng/mL | Influenza A virus | 1 | organism-based format | Scientific Literature | ||
20. | ALA699371 | F | Inhibitory concentration by Plaque reduction assay; range-1.9-12 | Influenza A virus | 1 | organism-based format | Scientific Literature |